A pproximately one-half of patients with heart failure (HF) have a preserved ejection fraction (HFpEF). 1 Diagnosis of HFpEF is straightforward when patients are acutely decompensated. However, among stable people presenting with chronic dyspnea, diagnosis is challenging and relies on identifying direct or indirect evidence of elevated left ventricular (LV) filling pressures. [1] [2] [3] [4] To make matters more complex, many patients with HFpEF display normal LV filling pressures at rest, with abnormalities that develop only during physiological stresses like exercise. [5] [6] [7] Invasive hemodynamic exercise testing has emerged as the gold standard to diagnose or exclude HFpEF in patients with exertional dyspnea of unclear etiology, 7 but cost, risk, and the requirement for specialized training and equipment may limit its broad application in practice and in clinical trials.
The American College of Cardiology Foundation/American Heart Association guidelines define HFpEF as clinical signs and symptoms of HF, preserved ejection fraction, and no other obvious explanation for symptoms. 8 This scheme works well for patients with a high likelihood of disease on the basis of clinical indicators of congestion such as jugular distention, gallop sounds, or edema. 9 To address the patients without overt congestion, more recent guideline statements from the European Society of Cardiology (ESC) and American Society of Echocardiography/European Association of Cardiovascular Imaging (ASE/EACVI) require objective evidence of high LV filling pressures, such as elevations in plasma natriuretic peptide (NP) levels and the ratio of transmitral E to mitral annular e′ velocities (E/e′). [2] [3] [4] Although this approach is supported by some studies, others have raised serious questions regarding their accuracy. 5, [9] [10] [11] [12] [13] [14] [15] [16] [17] It is important to note that no study has rigorously tested these more recently proposed algorithms for diagnosis of HFpEF by using gold standard, invasive data.
Accordingly, we performed a trial testing the performance characteristics of these diagnostic algorithms for HFpEF and the incremental utility of adding exercise echocardiography to improve diagnostic performance in patients presenting with normal ejection fraction and unexplained dyspnea.
METHODS
Consecutive subjects referred to the Mayo Clinic catheterization laboratory for invasive exercise right heart catheterization because of the indication of exertional dyspnea of unclear cause were prospectively enrolled between August 2011 and July 2013. Some participant data from this study has been published, 6, 18, 19 but not as it relates to the diagnostic evaluation of HFpEF. Written informed consent was provided by all patients before participation in study-related procedures. The authors had full access to the data and take responsibility for its integrity. All authors have read and agree to the article as written. The study was approved by the Mayo Clinic Institutional Review Board, and the study was registered (NCT01418248).
Study Population
All patients referred for exercise stress testing in the evaluation of exertional dyspnea were approached for participation in this trial. The current analysis is restricted to subjects with normal LV ejection fraction and either HFpEF or noncardiac dyspnea (NCD). HFpEF was defined by typical clinical symptoms (dyspnea, fatigue), normal LV ejection fraction (≥50%), elevated left heart filling pressures (pulmonary capillary wedge pressure, PCWP) at rest (>15 mm Hg) and/or with exercise (≥25 mm Hg), and exclusion of alternative causes of the clinical syndrome of HF: primary cardiomyopathies (hypertrophic, infiltrative, or restrictive), constrictive pericarditis, high-output heart failure, significant valvular heart disease (>moderate regurgitation or >mild stenosis), pulmonary embolism and right ventricular myopathies. Subjects with NCD (n=24) were required to display no cardiac pathology after thorough clinical evaluation, imaging, and invasive assessment, including normal rest and exercise mean pulmonary artery pressures (rest<25 mm Hg, exercise<40 mm Hg) and normal rest-exercise PCWP (criteria above).
Study Protocol
After providing consent, subjects underwent history, physical examination, and comprehensive resting echocardiogram
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to enable the sonographer to identify optimal imaging windows. Cardiac catheterization was then performed in the supine position with simultaneous echocardiography and expired gas analysis at rest and during cycle ergometry exercise. The first stage of exercise (20 W) was performed for 5 minutes and followed by graded 10 W increments in workload (3-minute stages) to subject-reported exhaustion.
Catheterization Protocol
Patients were studied on their chronic medications in the fasted state after minimal sedation as previously described. 5, 6, [18] [19] [20] [21] Right heart catheterization was performed through a 9F sheath via the right internal jugular vein. Pressures in the right atrium, right ventricular, pulmonary artery, and PCWP were measured at end expiration (mean of ≥3 beats) using 2F high-fidelity micromanometer-tipped catheters (Millar Instruments) advanced through the lumen of a 7F fluid-filled catheter (Balloon wedge, Arrow). Mean micromanometer pressures were calibrated to mean fluid-filled pressures at the beginning and throughout each case to avoid baseline drift.
Transducers were zeroed at midaxilla, measured by laser calipers in each patient. Pressure tracings from the entire study were digitized (250 Hz) and stored for offline analysis by 1 investigator experienced in exercise hemodynamic assessment (B.A.B.). Mean right atrium and PCWP were taken at mid-A wave. PCWP position was verified by typical waveforms, appearance on fluoroscopy, and direct oximetry (PCWP blood saturation≥94%). Arterial blood pressure was measured through a 4F to 6F radial arterial cannula throughout the tests. Arterial-venous O 2 content difference (AVo 2 diff) was measured directly as the difference between systemic arterial and Pao 2 content (=saturation×hem oglobin×1.34). Oxygen consumption (Vo 2 ) was measured from expired gas analysis (MedGraphics) to calculate cardiac output (CO), by the direct Fick method (CO= Vo 2 ÷AVo 2 diff) at baseline, 20 W, and peak exercise. Stroke volume was determined from the quotient of CO and heart rate.
Echocardiography
Comprehensive 2-dimensional, M-mode, Doppler and tissue Doppler echocardiography was performed according to contemporary guidelines by experienced sonographers. 4 Echocardiographic data were obtained simultaneously with invasive assessment at rest and during all stages of exercise. All studies were interpreted offline and in a completely blinded fashion by a single investigator with extensive experience in resting and exercise echocardiographic assessment (G.C.K.).
Early (E) transmitral filling velocities were measured at the mitral leaflet tips by pulse wave Doppler. Tissue Doppler echocardiography was performed to measure early (e′) diastolic tissue velocities at the septal and lateral mitral annulus. The mean of the septal and lateral E/e′ ratio was used as the primary estimate of PCWP. All measures represent the mean of measurements from 3 beats for subjects in sinus rhythm and the mean of 5 beats for subjects in atrial fibrillation.
Noninvasive Diagnosis of HFpEF
To evaluate the diagnostic performance of current algorithms and the potential value for exercise echocardiography, the diagnosis of HFpEF was first coded from resting echocardiographic data alone using contemporary diagnostic schemes as proposed by the ESC and separately according to recommendations from the ASE/EACVI for the assessment of diastolic dysfunction (online-only Data Supplement Figure IA and IB). 2, 4 Next, the diagnosis of HFpEF was coded after adding in the data obtained from exercise echocardiography according to the ASE/EACVI. 4 Specifically, the latter guidelines stipulate that diastolic dysfunction (in this case, HFpEF) can be coded if average E/e′>14 or septal E/e′>15 during exercise, peak tricuspid regurgitant (TR) velocity is >2.8 m/s, and septal e′ velocity is <7 cm/s (if only lateral e′ was acquired, values <10 cm/s considered abnormal). 4 Cases were coded as HFpEF if either 20 W or peak criteria (or both stages) were met. We also investigated the diagnostic value of adding exercise E/e′ alone (without requiring corroboratory evidence from TR velocity).
Statistical Analysis
Results are reported as mean (standard deviation), median (interquartile range) or number (%). Within-group differences are assessed by paired t test or repeated-measures analysis of variance. Between-group differences were compared by unpaired t test, Wilcoxon rank sum test, chi-square test or Fisher exact test as appropriate. Regression was used to assess correlation between invasive and noninvasive hemodynamic measures. Correlations are reported using the Spearman rank coefficient. C-statistics were derived from logistic regression analysis using HFpEF as the outcome.
RESULTS

Subject Characteristics
Of the 108 subjects enrolled in this prospective trial, 1 withdrew consent before the study, 1 developed transient heart block requiring transvenous pacing, and 32 did not meet entry criteria because of HF with reduced ejection fraction, significant valvular heart disease, or group 1 pulmonary hypertension. Of the remaining 74 participants, 24 (32%) were found to have NCD and 50 (68%) met prospectively defined criteria for HFpEF.
In comparison with NCD, subjects with HFpEF were older, more obese, hypertensive, anemic, and had more impaired renal function (Table 1) . LV structure and ejection fraction were similar in HFpEF and NCD. Peak exercise capacity reflected by maximal workload achieved was lower in HFpEF (36±15 versus 70±29 W, P<0.0001). Although N-terminal pro-B type natriuretic peptide (NT-proBNP) levels were higher in HFpEF than in NCD (Table 1) , 18%, 30%, and 40% of subjects with invasively proven HFpEF displayed NT-proBNP levels that fell below the thresholds considered to exclude HFpEF according to ESC consensus guidelines and eligibility criteria for enrollment in clinical trials (≤125, <225, and <300 pg/mL, respectively).
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Baseline Invasive and Noninvasive Hemodynamics
Subjects with HFpEF displayed higher right and left heart filling pressures with higher pulmonary artery pressures by catheterization in comparison with NCD (Table 2) . Medial and lateral E/e′ data were obtainable in almost all subjects at rest (99% and 95%, respectively). As expected, LV diastolic function was impaired in subjects with HFpEF in comparison with NCD, with higher transmitral E velocity, shorter deceleration time, lower medial and lateral e′ velocities, higher E/e′ ratio, larger left atrial (LA) volume index, and higher TR velocity (Tables 1 and  2 ). However, despite significant group differences, there was substantial overlap in these echocardiographic indices at rest (Figure 1 ). Medial and lateral E/e′ ratios were modestly correlated with directly measured PCWP at rest (r=0.63 and 0.58, P<0.0001; Figure 2 ).
Exercise Echocardiography-Catheterization Correlation
During submaximal (20 W) and peak exercise, subjects with HFpEF displayed higher left and right heart filling pressures, higher pulmonary artery pressures, and lower CO and cardiac index in comparison with NCD ( Table 2 ). The feasibility of obtaining diagnostic-quality echocardiographic measurements decreased during exercise, with the medial and lateral E/e′ obtainable in 89% and 86% of subjects at 20 W exercise, and 80% and 77% at peak exercise. TR velocities were obtainable in 54% of participants at 20 W exercise and 49% at peak exercise.
Medial E/e′ was higher, medial e′ velocity was lower, and TR velocity was higher in HFpEF patients than in NCD during exercise. However, there was again substantial overlap between HFpEF and NCD in the echocardiographic indicators of diastolic function during exercise, with the E/e′ ratio showing the best separation between groups ( Figure 3 ).
Among subjects with obtainable data, modest correlations between E/e′ and PCWP were again observed at 20 W and peak exercise ( Figure 2 ). However, in comparison with rest, exercise E/e′ underestimated PCWP during exercise (higher PCWP for any E/e′ value, interaction P=0.005, Figure 4A ). Absolute unit increases in E/e′ during exercise were much lower than unit changes in PCWP in both HFpEF and NCD subjects, indicating lower dynamic range for E/e′ ( Figure 4B and 4C). Medial E/e′ ratio was found to increase during exercise in HFpEF patients with normal rest filling pressures (P<0.001), but there was no change in E/e′ among HFpEF subjects with elevated resting PCWP (P=0.15, Figure 4D ).
Invasive and Noninvasive Approaches to Diagnose HFpEF
By definition, resting cardiac catheterization enabled diagnosis of HFpEF with perfect specificity, but misclassified 22 (44%) of the HFpEF patients as NCD on the basis of the absence of high PCWP at rest (Table 3, Figure 5 ). Addition of exercise invasive data thus significantly reclassified subjects beyond resting invasive data Data are mean±SD, median (interquartile range), or n (%). ACEI indicates angiotensin-converting enzyme inhibitors; ARB, angiotensinreceptor blockers; HF, heart failure; HFpEF, heart failure with preserved ejection fraction; JVP, jugular venous pressure; LA, left atrial; LV, left ventricular; NCD, noncardiac dyspnea; NT-proBNP, and N-terminal pro-Btype natriuretic peptide.
alone, confirming the incremental utility of invasive exercise testing beyond resting catheterization alone. 5 It is intriguing that use of PCWP with submaximal exercise (20 W) was nearly as effective as peak exercise data to discriminate HFpEF and NCD (Table 3) .
Next, we evaluated the performance of noninvasive rest and stress echocardiography algorithms endorsed by current guidelines. The ASE/EACVI algorithm to diagnose diastolic dysfunction 4 on the basis of resting echocardiography was poorly sensitive but fairly specific when used to identify or exclude HFpEF, with high positive predictive values but low negative predictive values (Table 3 , Figure 5) . The low sensitivity for this algorithm was caused by a large number of indeterminate subjects (online-only Data Supplement Figure I ) where incomplete data were available to characterize them (eg, unable to assess TR velocity) and by the substantial number of participants with high PCWP despite normal E/e′ values ( Figure 2) .
Next we applied the ESC algorithm for HFpEF diagnosis, which does not include indeterminate categories (online-only Data Supplement Figure I) . 3 The ESC criteria displayed higher sensitivity than the ASE/EACVI algorithm, but also had poor sensitivity and thus low negative predictive values (Table 3) . Adding exercise echocardiography criteria on the basis of the ASE/EACVI guidelines 4 to the ESC algorithm increased sensitivity modestly to diagnose HFpEF (Table 3 , Figure 5 ), but negative predictive value remained poor. A large number of subjects were classified as indeterminate by using ASE/EACVI guidelines for exercise echocardiography (n=54, 73%). This was predominantly related to the inability to assess diagnostic-quality TR velocities during exercise (n=37, 50%). To reduce data missingness and simplify the evaluation, we then determined whether addition of exercise E/e′ alone using published cutoffs for abnormal (average E/e′>14 or septal E/e′>15) to the ESC algorithm 3 would improve diagnostic performance. This decreased the number of unclassifiable exercise cases to 16 (22%). Addition of exercise E/e′ improved classification beyond the resting ESC criteria, with greater sensitivity and negative predictive value (Table 3) but an increase in the false-positive rate to 29% ( Figure 5 ). Addi- tion of exercise E/e′ during submaximal exercise only (20 W) also improved on the resting ESC criteria (Table 3) , but had less sensitivity in comparison with using the entire exercise E/e′ data. Addition of E/e′ with passive leg raise did not improve group discrimination in comparison with the ESC criteria ( Table 3 ). All correlations and comparisons were similar and remained significant after excluding subjects in atrial fibrillation (data not shown).
DISCUSSION
The diagnosis of HFpEF can be challenging. Current recommendations for evaluation are based on expert consensus opinion and have not been empirically tested. We performed a prospective, comprehensive simultaneous echocardiographic-cardiac catheterization study, conducted at rest and during exercise, to evaluate and compare the utility of current approaches proposed by the ESC and ASE/EACVI to diagnose or exclude HFpEF, and identify whether addition of exercise echocardiography to current algorithms enhances diagnostic performance. We found that normal NP levels, which are considered by some to exclude disease, were common in subjects with invasively proven HFpEF. Diagnostic-quality echocardiographic indices, in particular TR velocity, could not be obtained during exercise in a large proportion of participants, and even when feasibly obtained, these indices displayed substantial overlap between HFpEF and NCD. E/e′ ratio could be measured with greater completeness and was modestly correlated with directly measured PCWP at rest and during exercise. The ESC and ASE diagnostic algorithms for HFpEF were specific but displayed poor sensitivity. Addition of exercise E/e′ alone (>14) to the currently proposed ESC diagnostic Figure 1 . Baseline echocardiographic parameters shown in heart failure with preserved ejection fraction (HFpEF) and noncardiac dyspnea (NCD).
A, Medial E/e′ ratio. algorithm improved sensitivity with an incremental diagnostic value. These data have several key implications: they question the utility of evaluations for HFpEF on the basis of resting data alone, they suggest that addition of exercise echocardiography may be useful to exclude HFpEF (when diagnostic-quality images are unequivocally normal), and they reinforce the value of invasive diastolic stress testing to definitively confirm or refute the diagnosis of HFpEF in patients presenting with unexplained exertional dyspnea.
Noninvasive Diagnosis of HFpEF Using Rest Data
Echocardiography plays a critical role in the evaluation of HFpEF. As expected, we observed many differences in echocardiography-Doppler indices of diastolic relaxation, compliance and filling pressures comparing cases and controls. Despite these differences, there was substantial overlap between groups (Figures 1 and 3) . Recent guidelines from the ESC 3 have been proposed to diagnose or rule out HFpEF in clinical practice, but their accuracy is yet to be validated. Similarly, the ASE/EACVI writing committee has developed guidelines for the diagnosis of diastolic dysfunction, 4 which were also tested in this study because diastolic dysfunction has been considered to be necessary to secure the diagnosis of HFpEF. 2 Although it is important to emphasize that diastolic dysfunction does not guarantee clinical HFpEF, 1 it is also notable that >60% of subjects with invasively confirmed HFpEF did not meet criteria for diastolic dysfunction as Among subjects with obtainable data, medial and lateral E/e′ ratios were modestly correlated with directly measured pulmonary capillary wedge pressure (PCWP) at rest, submaximal exercise (20 W), and peak exercise. The feasibility of obtaining diagnosticquality echocardiographic measurements decreased during exercise.
proposed by the ASE/EACVI guidelines. 4 Thus, although the ASE/EACVI criteria are quite specific, there is limited sensitivity.
The E/e′ ratio is central to both algorithms, serving as a lynchpin in the noninvasive assessment of LV filling pressures. 2, 4 Despite its widespread use, there are conflicting data on the accuracy of E/e′ to estimate PCWP. Early studies showed modest but significant correlations between E/e′ and filling pressures at rest. 4, 11, 22 Ommen et al 11 reported excellent specificity with E/e′, but there were many patients with high filling pressures despite normal E/e′, similar to what we observed at rest in the current study. Thus, it is reasonable to conclude that an elevated resting E/e′ strongly supports the presence of high PCWP and thus HFpEF, but that a normal resting E/e′ does not exclude HFpEF.
We observed that 18% of subjects with invasively proven HFpEF displayed completely normal NT-proBNP (<125 pg/mL), a level proposed in the most recent ESC guideline statement to effectively exclude HF. 3 A larger number of subjects with HFpEF (30% and 40%) displayed NTproBNP levels below other partition values that have been suggested to rule out HFpEF (<225 and <300 pg/mL). Although it has been suggested that normal NP levels can exclude HF in the outpatient setting, 23 one cannot definitively rule out a disease without performing the gold standard test (invasive hemodynamic stress testing). In this light, 2 previous studies have clearly demonstrated that In comparison with NCD, medial E/e′ was higher, medial e′ velocity was lower, and TR velocity was higher in HFpEF patients during submaximal (20 W) (A through C) and peak exercise (D through F). However, there was still substantial overlap between HFpEF and NCD in these echocardiographic markers during exercise, with the E/e′ ratio showing the best separation between the groups. HFpEF indicates heart failure with preserved ejection fraction; NCD, noncardiac dyspnea; and TR tricuspid regurgitant.
hemodynamic proof of HFpEF is present in a substantial number of patients with normal NT-proBNP levels, either when assessed at rest 10 or during exercise. 5 Indeed, it is well known that NP levels are lower in HFpEF than HF with reduced ejection fraction. This observation is believed to be primarily related to 2 factors: lower wall stress owing to smaller chamber size and thicker ventricular walls, and greater prevalence of obesity which suppresses NP levels.
1 Thus, the current data, in light of these prior studies, clearly demonstrate that like normal E/e′ ratios, normal NP levels do not exclude the diagnosis of HFpEF, particularly among patients with early-stage HFpEF, which includes the majority of subjects participating in this study.
The Incremental Utility of Exercise Testing in HFpEF Evaluation
The diagnosis of HFpEF in people presenting with unexplained dyspnea is problematic because many afflicted patients develop pathological elevations in the filling pressures only during exercise, in the absence of congestion at rest. 5 Invasive hemodynamic exercise testing serves as the gold standard to make or refute the diagnosis of HFpEF in these patients, as confirmed in the current study, but is limited by increased cost, the requirement for specialized equipment and operator expertise, and relatively small but measurable risk. These limitations form the basis for the noninvasive diastolic stress test to evaluate for HFpEF, which has been proposed as a means to enhance diagnosis of HFpEF and diastolic dysfunction. 3, 4 Although some groups have demonstrated significant correlations between E/e′ and filling pressures during exercise, [12] [13] [14] others have observed little to no relationship between echocardiographic and invasive indices. [15] [16] [17] It is important to note that very few data are available evaluating simultaneous assessment, as in the current study.
We found that when diagnostic-quality E/e′ data could be obtained during exercise (80%-85% of the time), there were modest correlations between E/e′ and directly measured PCWP (r=0.5-0.6). It is notable that the relationship shifted during exercise, such that PCWP values were higher for a given E/e′ with exercise in comparison with rest ( Figure 4) . Sensitivity for the ESC Figure 4 . Relationships between invasive and noninvasive estimated filling pressures during exercise.
A, In comparison with rest, exercise E/e′ underestimated PCWP during exercise. 95% CIs on regression lines are for the best-fit mean line. Interaction P value reflects the difference in slopes in the regression between E/e′ and PCWP at rest and during exercise. B, Absolute values of PCWP and medial E/e′ during exercise for HFpEF and NCD. Error bars indicate SEM. P values at the top reflect a 1-way repeated-measures ANOVA testing whether PCWP or E/e′ changes during exercise stages in HFpEF and NCD. †P<0.05 versus at rest; #P<0.05 versus 20 W exercise. C, Absolute unit increases (ie, changes from baseline, Δ) in both medial and lateral E/e′ were much lower than unit changes in PCWP in both HFpEF and NCD at 20 W (Left) and peak exercise (Right). Error bars indicate SD. *P<0.05 versus PCWP. D, In comparison with HFpEF with elevated resting PCWP, changes with exercise (Δ) in medial E/e′ were greater in HFpEF with normal rest filling pressures both submaximal (20 W) and peak exercise. Error bars indicate SD. ‡P<0.05 versus HFpEF with rest PCWP >15 mm Hg. ANOVA indicates analysis of variance; HFpEF, heart failure with preserved ejection fraction; NCD, noncardiac dyspnea; PCWP, pulmonary capillary wedge pressure; SD, standard deviation; and SEM, standard error of the mean. algorithm 3 was improved following addition of exercise E/e′, suggesting that adding exercise E/e′ alone may be useful to rule out HFpEF if it is completely normal. However, the false-positive rate also increased with addition of exercise E/e′, suggesting that confirmatory invasive testing may be required if exercise E/e′ is abnormal in this population.
Rather than relying exclusively on E/e′ during exercise echocardiography, the ASE/EACVI has proposed an integrated multimarker interpretation scheme on the basis of E/e′, septal e′, and TR velocity, which we tested in this study. 4 We observe that application of this exercise echocardiography grading scheme only nominally improved HFpEF classification, and was not as robust as exercise E/e′ alone. This was related largely to the inability to obtain diagnostic-quality TR velocity during exercise in a number of patients. Thus, although the ASE/ EACVI algorithm is pathophysiologically sound, its complexity and reduced feasibility for obtaining complete data during exercise are significant shortcomings, and the current data suggest that it may be best to focus the examination on accurately measuring E/e′ during exercise rather than relying on too many different indices. Although assessment of E/e′ with passive leg raise was not incrementally useful, we observed fairly similar discriminatory ability of E/e′ with submaximal exercise (20 W) as using E/e′ data from all stages of exercise (Table 3) . However, sensitivity was reduced with this approach, leading to a lower negative predictive value, and suggesting that a peak effort noninvasive exercise test might be optimal. In contrast, measuring PCWP at 20 W alone discriminated HFpEF from NCD with very high sensitivity and perfect specificity. Although some might consider this finding as being sufficient to abandon maximal invasive exercise testing, it is important to consider that other valuable information can be obtained with peak testing, including insight on the roles of cardiac versus peripheral factors in limiting exercise capacity 19, [24] [25] [26] [27] [28] and more detailed understanding of pulmonary vascular physiology.
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Clinical Implications
The current data clearly show that many patients with HFpEF will be missed if the diagnosis relies exclusively on resting clinical data and echocardiography, because the sensitivities for contemporary diagnostic algorithms proposed by the ESC and ASE/EACVI were very low (34%-60%). The sensitivity of resting cardiac catheterization was similarly poor in this series (56%), because filling pressures are frequently normal at rest in ambulatory patients with HFpEF. 5, 6 Which individuals then should undergo noninvasive diastolic stress testing, and which should undergo the gold standard of invasive diastolic stress testing? As with all diagnostic tests, the answer depends on Bayesian theory and the pretest probability of disease.
A patient with many features of HFpEF on the basis of initial evaluation (eg, older age, typical comorbidities like obesity, specific signs and symptoms like jugular distention, peripheral edema, and orthopnea, clinical improvement with diuresis, cardiac limitation on noninvasive cardiopulmonary testing) has a very high pretest probability, meaning that even a negative exercise echocardiogram would not sufficiently reduce the posttest probability. Consistent with the American College of Cardiology Foundation/American Heart Association guidelines, the diagnosis of HFpEF can be made clinically in this circumstance and no further testing is required. 8 In contrast, a patient with no features of HFpEF would have such a low pretest probability that even a positive exercise echocardiogram would not sufficiently increase the posttest probability to a level where one can feel secure in the diagnosis of HFpEF.
The noninvasive diastolic exercise stress test will be most useful in patients with intermediate pretest probabilities, such as the subjects enrolled in this study, where the high sensitivity afforded by exercise E/e′ provides reasonably strong negative predictive value to rule out HFpEF. For example, according to the current data, a finding of a normal exercise echocardiogram in a patient with a ≈40% pretest probability of HFpEF would lower the posttest probability to 9%. It would be safe to conclude with a reasonably high degree of confidence that this patient does not have HFpEF. However, if this same patient had a positive exercise echocardiogram, the posttest probability would be only 67%, indicating a need for further confirmatory testing, because of the higher rate of false-positive studies with exercise echocardiography.
Accordingly, on the basis of these data, we propose a diagnostic approach as illustrated in Figure 6 . Patients with very low or very high pretest probabilities should not undergo noninvasive diastolic exercise testing. If definitive diagnosis is necessary in these patients, the gold standard test should be used. In patients with intermediate pretest probability and adequate echocardiographic windows for imaging, it is reasonable to perform noninvasive diastolic stress testing. If this is negative, the likelihood of disease is low and further testing is probably not required. However, if the noninvasive diastolic stress test is abnormal, then the gold standard of invasive exercise stress testing should be performed to confirm the diagnosis given the higher false-positive rate. If echocardiographic imaging is of poor quality or is equivocal, invasive exercise testing should also be performed.
This approach may be useful to optimize the diagnostic evaluation for routine practice, and could even be applied as an alternate eligibility criterion for clinical trials, which currently require invasive confirmation or elevation in NP levels. If invasive exercise testing is not available at some centers because of the need for specialized equipment and dedicated staff, referral to a tertiary center where this testing is available should be considered.
Limitations
This is a single-center study from a tertiary referral center and as such has inherent flaws relating to selection and referral bias. The sample size is moderate, and this limits additional subgroup analyses. Further prospective validation of these diagnostic approaches is warranted, in particular, the proposed algorithm shown in Figure 6 , which is based on, but was not prospectively tested in this study. Although echocardiography was performed by rigorously trained, dedicated research sonographers, the performance in the supine, draped patient in the catheterization laboratory may have negatively impacted the availability and alignment of Doppler data, particularly tricuspid regurgitant velocities. Alternatively, the proportion of patients in the community where diagnostic quality images can be obtained during exercise may be much lower than what we observed in this highly controlled environment. The diagnostic algorithm proposed relies on being able to accurately estimate the pretest probability of HFpEF, which was not evaluated in this study but is currently done on the basis of clinical judgment alone. Further study is required to better quantify the pretest probability of HFpEF on the basis of clinical characteristics and resting echocardiographic data to optimally apply these data.
CONCLUSIONS
Approaches to identify diastolic dysfunction and HFpEF from resting data are poorly sensitive, and the absence of elevation in surrogates of filling pressure like plasma NP levels or E/e′ does not rule out HFpEF. The E/e′ ratio is moderately correlated with directly measured filling pressures at rest and during exercise, and addition of exercise E/e′ data to the ESC diagnostic guidelines improves sensitivity that may enable exclusion of HFpEF in patients with low to intermediate pretest probabilities of disease. Invasive hemodynamic testing may be highest yield in patients with inadequate imaging windows, equivocal noninvasive data, or abnormal noninvasive exercise testing results to definitively confirm or refute the diagnosis of HFpEF. In a patient with normal EF suspected of HFpEF, assessment of pretest probability is performed on the basis of clinical characteristics, physical examination, natriuretic peptide levels, and rest imaging. Patients with very few or most of these characteristics are very unlikely or very likely (respectively) to have HFpEF, and the diagnosis can be made with reasonable confidence in these groups without further testing. If diagnosis is needed with certainty in this cohort, then the gold standard of invasive exercise testing should be performed because exercise echo results may not sufficiently change the posttest probability if discordant with the pretest likelihood. Rest Doppler echocardiography (E/e′) has reasonable specificity but poor sensitivity for the diagnosis of HFpEF. For patients with intermediate pretest probability, exercise echocardiography focused on E/e′ should be considered. If this is normal, the likelihood of HFpEF is low and further testing is not likely required. However, a positive exercise echo should prompt consideration for exercise cath to confirm the diagnosis because of the higher false-positive rate. An equivocal or nondiagnostic exercise echo should also prompt consideration of invasive diastolic stress testing to clarify the diagnosis. Invasive testing at rest has poor sensitivity and all patients with suspected HFpEF referred for cardiac catheterization should undergo invasive exercise testing if the PCWP at rest is normal. cath indicates catheterization; echo, echocardiography; EF, ejection fraction; HFpEF, heart failure with preserved ejection fraction; LV, left ventricular; NT-proBNP, N-terminal pro-B type natriuretic peptide; and PCWP, pulmonary capillary wedge pressure.
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